RxDoctor Payments Data

Alireza Malekzadeh, MD

Orthopaedic Surgery · Fairfax, VANPI 1932135662

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $10,473 of the $17,412 with a category attached, or 60.1%. Medical Device Business Services, Inc. accounts for 70.6% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2020 at $7,334 and has fallen 98.8% since, to $88 in 2025.

$17,412in general payments, 2019–2025

Across 38 payments — averaging $458.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$12K
  • Synthes GmbH$4K
  • Johnson & Johnson$650
  • Stryker$442
  • Zimmer Biomet$141
  • Kerecis Limited$48
  • plus $67 from 2 others
$3,695in research payments, 2019–2025

Across 2 payments — averaging $1847.55 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medical Device Business Services, Inc.$4K

What the payments were for

  • Consulting fees$10,47360%
  • Speaking & faculty fees$2,50014%
  • Travel & lodging$2,60415%
  • Food & beverage$1,83411%

General payments by program year

19
20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$17,412 in reported general payments places this provider in the 75th percentile of 473 orthopaedic surgery providers in Virginia.

See all orthopaedic surgery providers in Virginia →

Medicare billing

Part B allowed, 2024
$181,945
Medicare patients
255
Services billed
705

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other orthopaedic surgery in Fairfax

See the full list for Virginia →

Where these figures come from

Is this you, or does something look wrong? →